参考文献/References:
[1] Grosman-Rimon L,Billia F,Wright E,et al. Neurohormones,inflammatory mediators,and cardiovascular injury in the setting of heart failure[J]. Heart Fail Rev,2020,25(5):685-701.
[2] Besedovsky H,Sorkin E. Network of immune-neuroendocrine interactions[J]. Clin Exp Immunol,1977,27(1):1-12.
[3] Mannozzi J,Al-Hassan MH,Kaur J,et al. Ventricular-vascular uncoupling in heart failure:effects of arterial baroreflex-induced sympathoexcitation at rest and during exercise[J]. Front Physiol,2022,13:835951.
[4] Oshaghi M,Kourosh-Arami M,Roozbehkia M. Role of neurotransmitters in immune-mediated inflammatory disorders:a crosstalk between the nervous and immune systems[J]. Neurol Sci,2023,44(1):99-113.
[5] Levite M. Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors[J]. Curr Opin Pharmacol,2008,8(4):460-471.
[6] Hodo TW,de Aquino MTP,Shimamoto A,et al. Critical neurotransmitters in the neuroimmune network[J]. Front Immunol,2020,11:1869.
[7] Dehlin HM,Levick SP. Substance P in heart failure:the good and the bad[J]. Int J Cardiol,2014,170(3):270-277.
[8] Moratal C,Laurain A,Na?mi M,et al. Regulation of monocytes/macrophages by the renin-angiotensin system in d iabetic nephropathy:state of the art and results of a pilot study[J]. Int J Mol Sci,2021,22(11):6009.
[9] Wu YJ,Wang L,Ji CF,et al. The role of α7nAChR-mediated cholinergic anti-inflammatory pathway in immune cells[J]. Inflammation,2021,44(3):821-834.
[10] Karmakar S,Lal G. Role of serotonin receptor signaling in cancer cells and anti-tumor immunity[J]. Theranostics,2021,11(11):5296-5312.
[11] Sharma D,Farrar JD. Adrenergic regulation of immune cell function and inflammation[J]. Semin Immunopathol,2020,42(6):709-717.
[12] Guereschi MG,Araujo LP,Maricato JT,et al. Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner[J]. Eur J Immunol,2013,43(4):1001-1012.
[13] Kenney MJ,Ganta CK. Autonomic nervous system and immune system interactions[J]. Compr Physiol,2014,4(3):1177-1200.
[14] de Angelis E,Pecoraro M,Rusciano MR,et al. Cross-talk between neurohormonal pathways and the immune system in heart failure:a review of the literature[J]. Int J Mol Sci,2019,20(7):1698.
[15] Kelly MJ,Breathnach C,Tracey KJ,et al. Manipulation of the inflammatory reflex as a therapeutic strategy[J]. Cell Rep Med,2022,3(7):100696.
[16] Gao XM,Tsai A,Al-Sharea A,et al. Inhibition of the renin-angiotensin system post myocardial infarction prevents inflammation-associated acute cardiac rupture[J]. Cardiovasc Drugs Ther,2017,31(2):145-156.
[17] Belali OM,Ahmed MM,Mohany M,et al. LCZ696 protects against diabetic cardiomyopathy-induced myocardial inflammation,ER stress,and apoptosis through inhibiting AGEs/NF-κB and PERK/CHOP signaling pathways[J]. Int J Mol Sci,2022,23(3):1288.
[18] Li B,Liao YH,Cheng X,et al. Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction[J]. Int J Cardiol,2006,111(2):247-255.
[19] Xiao H,Song Y,Li Y,et al. Qiliqiangxin regulates the balance between tumor necrosis factor-α and interleukin-10 and improves cardiac function in rats with myocardial infarction[J]. Cell Immunol,2009,260(1):51-55.
[20] Wang J,Yu Q,Dai M,et al. Carotid baroreceptor stimulation improves cardiac performance and reverses ventricular remodelling in canines with pacing-induced heart failure[J]. Life Sci,2019,222:13-21.
[21] Lipov E,Gluncic V,Luki? IK,et al. How does stellate ganglion block alleviate immunologically-linked disorders?[J]. Med Hypotheses,2020,144:110000.
[22] Zhang D,Hu W,Tu H,et al. Macrophage depletion in stellate ganglia alleviates cardiac sympathetic overactivation and ventricular arrhythmogenesis by attenuating neuroinflammation in heart failure[J]. Basic Res Cardiol,2021,116(1):28.
[23] Sabbah HN,Gupta RC,Rastogi S,et al. Treating heart failure with cardiac contractility modulation electrical signals[J]. Curr Heart Fail Rep,2006,3(1):21-24.
[24] Xiao L,Kirabo A,Wu J,et al. Renal denervation prevents immune cell activation and renal inflammation in angiotensin Ⅱ-induced hypertension[J]. Circ Res,2015,117(6):547-557.
[25] Li C,Xia W,Wang L,et al. Effect of renal denervation on cardiac function and inflammatory factors in heart failure after myocardial infarction[J]. J Cardiovasc Pharmacol,2020,76(5):602-609.
[26] Zhang M,Du Q,Yang F,et al. Acupuncture at PC6 prevents cardiac hypertrophy in isoproterenol-treated mice[J]. Acupunct Med,2019,37(1): 55-63.
[27] Wu Z,Xia Y,Wang C,et al. Electroacupuncture at Neiguan(PC6) attenuates cardiac dysfunction caused by cecal ligation and puncture via the vagus nerve[J]. Biomed Pharmacother,2023,162:114600.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(11):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(11):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(11):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(11):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(11):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(11):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(11):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(11):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(11):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(11):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]